Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

David C. Habiger

At a glance: David C. Habiger is Director at Boston Scientific (BSX). Their latest SEC Form 4, filed Aug 7, 2026, reported a purchase of $100K. On file: 5 purchase lines ($408K) and 0 sale lines ($0).

Disclosed holdings: about $733K of BSX stock: 17,160 shares reported on their latest Form 4 (filed Aug 7, 2026), valued at the Nov 20, 2026 close of $42.72. This counts only BSX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Boston Scientific Corp (BSX)

Purchase track record

Below average. Based on 3 purchases with a full 90 days of price history.

34
Avg. 90-day return-9.1%
vs. S&P 500-8.1%
Beat the market0%
Paper profit on buys−$78K
Total bought / sold$408K / $0

David C. Habiger's InsiderPrint

14 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of David C. Habiger: 14 trades, 2020 to 20262020: 4 buys, 0 sales2021: 0 buys, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 3 buys, 0 sales2025: 2 buys, 0 sales2026: 5 buys, 0 sales

Reading this print: Almost only buys, trading about 2 times a year, typically $50K a trade.

  • Bump outward: a purchase (14)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Peter Francis MinanCFO, President · NVRI · 99% match
  2. Evan BayhDirector · FITB · 99% match
  3. Paul BisaroDirector · MYGN · 98% match
  4. Gregory L. WeaverCFO · ALT · 98% matchTheir buys since 2023: 1 of 4 beat the S&P 500
  5. Robert J. LipsteinDirector · QRHC · 98% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2026

From the SEC's insider data sets: each open-market buy by David C. Habiger, matched to how the stock did over the next 90 days against the S&P 500.

0 of 2 buys beat the S&P 500 (0%), median -8.6% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
BSXAug 7, 2026-4.5%
BSXMay 21, 2026-12.8%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 7SEC BSXBoston Scientific CorpPast buys 0/2 beat S&P Buy 2,10017,160 held (+14%) $47.59 $100K -10.2%
Aug 5SEC BSXBoston Scientific CorpPast buys 0/2 beat S&P Buy 1,04214,920 held (+8%) $48.07 $50K -11.1%
Aug 5SEC BSXBoston Scientific CorpPast buys 0/2 beat S&P Buy 14015,060 held (+1%) $48.59 $7K -12.1%
May 21SEC BSXBoston Scientific CorpFirst buyPast buys 0/2 beat S&P Buy 2,20011,628 held (+23%) $56.95 $125K -25.0%
May 21SEC BSXBoston Scientific CorpFirst buyPast buys 0/2 beat S&P Buy 2,25013,878 held (+19%) $55.92 $126K -23.6%
  • Buy

    Director David C Habiger bought $125K of BSX at $56.95 — first open-market purchase in our records; raises the stake by 23%.

Follow David C. Habiger

Get one email when David C. Habiger files a new purchase or sale. Free.

At most one email a day about David C. Habiger, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.